Rotate device

Please turn your device

Bormioli Pharma at Pharmapack Europe.

06 February 2019 1 min reading

Based on the concept “Small part, Big Impact”, the new identity reflects the company’s “new wave”. Among the pillars of this drive for change, Bormioli Pharma is rolling out an innovative model featuring a more open, distributed approach, the unification of corporate marketing and innovation functions, as well as a growing attention to consumer needs and market trends and the presentation of products in an innovative way.

Bormioli Pharma, leading global producer in the pharma packaging market, will attend to Pharmapack Europe, the leading European event for pharmaceutical packaging, drug delivery, medical devices and machinery, connecting pharma packaging producers and clients. The trade fair will take place at Paris Expo, Porte de Versailles, the French capital’s exhibition center, on 6th and 7th February.

The company’s management will be present at booth A66 of the fair to meet stakeholders and discuss Bormioli Pharma’s growth plans and innovative projects.

In a pharmaceutical market in which the drive for change is getting increasingly stronger, the company is implementing a five-year strategic plan. Among its pillars, together with the company’s internationalization, enhancement of efficiency of existing platforms and increase of productivity, is the design of a new model of innovation, a considerable drive based on four columns:

– A more open, distributed approach, integrating internal R&D projects with start-ups and incubators – such as Le Village by Crédit Agricole – and involving clients and final users to achieve big impact from true innovation

A new disruptive corporate structure, unifying marketing and innovation functions to better intercept the needs and trends of the market and to ensure a faster go-to-market

– A growing attention to intercept new consumer needs – putting patients at the center of the stage – and external trends, such as digital and sustainability.

A presentation of products in a new, innovative way. A first example will be shown at Pharmapack Europe, with a brand-new experience offered to visitors with an interactive installation curated by the Italian architect and innovator Carlo Ratti.

The new brand identity – unveiled for the first time during Pharmapack Europe – will be the manifesto of this new Bormioli Pharma, giving life to the very concept that animates the company’s behavior every day: Small part, Big impact. This means striving for perfection and continuous innovation, aware that the difference between great success and failure lives in the detail, always with the aim of putting the health in the hands of patients.

06 February 2019